AstraZeneca · 1 day ago
Global Commercial Director, Radioconjugates, Prostate Cancer
Gaithersburg, MD
Full-time
Onsite
Director/Executive
$229K/yr - $344K/yrAstraZeneca is seeking a Global Commercial Director for Radioconjugates focused on Prostate Cancer. This role involves leading the brand team, developing marketing strategies, ensuring budget compliance, and managing cross-functional activities across various brands.
BiopharmaBiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
Responsibilities
Leads and develops the brand team including but not limited to performance management, talent management and career development
Leads activities across brands, including the definition, design, execution and measurement of all marketing strategies and tactics to deliver on the brands’ objectives
Responsible for budgetary compliance
Coordinates regularly with sales, direct to consumer, and managed markets teams
Qualification
Required
Bachelor's Degree
Demonstrated ability to manage and lead large teams
Demonstrated Level 3 abilities across all 6 AZ Leadership Capabilities
Comprehensive understanding of the development and commercialization of pharmaceutical products in the US
Comprehensive understanding of the US Healthcare environment
Preferred
MBA in relevant field
Experience in Consumer and/or Managed Markets role
Sales and/or Sales Leadership experience
Experience in Emerging or DFL role
Benefits
Short-term incentive bonus opportunity
Equity-based long-term incentive program
Retirement contribution (hourly roles)
Commission payment eligibility (sales roles)
Qualified retirement program [401(k) plan]
Paid vacation and holidays
Paid leaves
Health benefits including medical, prescription drug, dental, and vision coverage
Company
AstraZeneca
AstraZeneca is a pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines. It is a sub-organization of Investor.
Founded in 1999
10001+ employees
Funding
Current Stage
Public CompanyTotal Funding
$5.26B2024-07-30Post Ipo Debt· $1.51B
2023-02-28Post Ipo Debt· $2.25B
2023-02-24Post Ipo Debt· $1.5B
Leadership Team
Pascal Soriot
Chief Executive Officer
Aradhana Sarin
Group CFO and Executive Director
Recent News
2026-01-23
Pharma Letter
2026-01-22
Company data provided by crunchbase